Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Other Non Operating Income: 2019-2025

Historic Other Non Operating Income for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $11,000.

  • Benitec Biopharma's Other Non Operating Income rose 109.32% to $11,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $714,000, marking a year-over-year increase of 1652.17%. This contributed to the annual value of $764,000 for FY2025, which is 474.51% up from last year.
  • Per Benitec Biopharma's latest filing, its Other Non Operating Income stood at $11,000 for Q1 2025, which was down 98.56% from $764,000 recorded in Q4 2024.
  • Benitec Biopharma's Other Non Operating Income's 5-year high stood at $764,000 during Q4 2024, with a 5-year trough of -$507,000 in Q3 2022.
  • In the last 3 years, Benitec Biopharma's Other Non Operating Income had a median value of -$24,000 in 2023 and averaged $69,222.
  • In the last 5 years, Benitec Biopharma's Other Non Operating Income plummeted by 1,500.00% in 2021 and then soared by 402.63% in 2024.
  • Over the past 5 years, Benitec Biopharma's Other Non Operating Income (Quarterly) stood at $48,000 in 2021, then skyrocketed by 235.42% to $161,000 in 2022, then fell by 5.59% to $152,000 in 2023, then soared by 402.63% to $764,000 in 2024, then soared by 109.32% to $11,000 in 2025.
  • Its last three reported values are $11,000 in Q1 2025, $764,000 for Q4 2024, and $93,000 during Q3 2024.